24th Mar 2015 07:01
Low & Bonar PLC
Appointment of Non-executive Director
Low & Bonar PLC ("Low & Bonar" or the "Group"), the international performance materials group, is pleased to announce the appointment of Kevin Matthews as a non-executive director with effect from 1 April 2015.
Kevin Matthews is Chief Executive Officer of Revolymer plc, an AIM listed company that designs, develops and formulates novel polymers to improve the performance of consumer products within the FMCG and other industrial markets. From 2009 to 2014, he was Chief Executive Officer of Isogenica Limited, a UK based private biotechnology business. Kevin was also a non-executive director of Elementis PLC (a FTSE 250 specialty chemicals company) from 2005 to 2014 including being chairman of its Remuneration Committee.
There is no further information required to be disclosed in relation to Mr Matthews pursuant to Listing Rule 9.6.13 R.
Martin Flower, Chairman of Low & Bonar, comments:
"We are delighted to welcome Kevin to the Group. His extensive experience in technology and specialty chemicals businesses will be of great value to the Board as the Group pursues its strategy of profitable growth through internationalisation and innovation."
For further information, please contact:
Low & Bonar PLC | 020 7535 3180 |
Brett Simpson, Group Chief Executive | |
Mike Holt, Group Finance Director | |
Instinctif | 020 7457 2020 |
Matthew Smallwood | |
Helen Tarbet |
Notes to Editors
Kevin Matthews's former appointments have included: CEO of Isogenica Limited; non-executive director of Elementis PLC; CEO of Oxonica plc, a UK based nanotechnology company, from 2001 to 2009; roles in Rhodia Consumer Specialties Limited, Albright & Wilson UK Limited and ICI Chemicals and Polymers: non-executive director of Cellectricon AB, a Swedish private biotechnology business (2011-2014); he holds a D.Phil in chemistry.
Related Shares:
LWB.L